# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA732617 | B | Binding affinity for human recombinant Mitogen-activated protein kinase p38 in a fluorescent binding assay | Homo sapiens | 44 | ALA1135498 | protein format | Scientific Literature | |
2. | ALA732620 | B | Evaluated for inhibition of human mitogen-activated protein kinase p38 | 36 | ALA1137075 | protein format | Scientific Literature | ||
3. | ALA1614459 | F | PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) | Drosophila | 88,408 | ALA1201862 | assay format | PubChem BioAssays | |
4. | ALA1614281 | F | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | Homo sapiens | 12,194 | ALA1201862 | assay format | PubChem BioAssays | |
5. | ALA1614087 | F | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | Mus musculus | 51,950 | ALA1201862 | assay format | PubChem BioAssays | |
6. | ALA1614361 | F | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | Homo sapiens | 16,181 | ALA1201862 | assay format | PubChem BioAssays | |
7. | ALA2114775 | F | PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) | 75,092 | ALA1201862 | assay format | PubChem BioAssays | ||
8. | ALA2114810 | F | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | Homo sapiens | 86,035 | ALA1201862 | assay format | PubChem BioAssays | |
9. | ALA2411641 | B | Activation of GIRK2/3 (unknown origin) | Homo sapiens | 14 | ALA2406941 | protein complex format | Scientific Literature | |
10. | ALA2411649 | B | Activation of GIRK1/4 (unknown origin) relative to control | Homo sapiens | 2 | ALA2406941 | protein complex format | Scientific Literature | |
11. | ALA2411650 | B | Activation of GIRK1/2 (unknown origin) by thallium flux assay relative to control | Homo sapiens | 2 | ALA2406941 | protein complex format | Scientific Literature | |
12. | ALA2411651 | B | Activation of GIRK1/4 (unknown origin) | Homo sapiens | 20 | ALA2406941 | protein complex format | Scientific Literature | |
13. | ALA2411652 | B | Activation of GIRK1/2 (unknown origin) by thallium flux assay | Homo sapiens | 2 | ALA2406941 | protein complex format | Scientific Literature | |
14. | ALA2424000 | B | Activation of GIRK1/4 (unknown origin) by cell-based thallium flux assay relative to control | Homo sapiens | 7 | ALA2417534 | cell-based format | Scientific Literature | |
15. | ALA2424001 | B | Activation of GIRK1/4 (unknown origin) by cell-based thallium flux assay | Homo sapiens | 7 | ALA2417534 | cell-based format | Scientific Literature | |
16. | ALA2424002 | B | Activation of GIRK1/2 (unknown origin) by cell-based thallium flux assay | Homo sapiens | 7 | ALA2417534 | cell-based format | Scientific Literature | |
17. | ALA2424003 | B | Activation of GIRK1/2 (unknown origin) by cell-based thallium flux assay relative to control | Homo sapiens | 7 | ALA2417534 | cell-based format | Scientific Literature | |
18. | ALA4495582 | F | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | ALA4495564 | assay format | SARS-CoV-2 Screening Data 2020-21 | |
19. | ALA4513082 | F | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 7,212 | ALA4495565 | organism-based format | SARS-CoV-2 Screening Data 2020-21 |